The PennZone

PITTSBURGH - PennZone -- SNS Intelligence announced the official launch of the SNS Market Intelligence Platform, a next-generation solution designed to replace static reports with an interactive market intelligence portal. The platform delivers structured market and drug development pipeline data through a cloud-based dashboard featuring advanced filters, slicers, and dynamic visualizations.

SNS Market Intelligence Platform Key Features:

• Clinical and late-stage pipeline tracking: Comprehensive tracking of assets from preclinical through pre-registration, structured to support portfolio planning and competitive intelligence.
• Market size estimates and long-term forecasts covering Therapeutic Category, Drug Delivery Route, Drug Type, Distribution Channel, Drug Class, Regional & Country markets
• • Analyze the data using filters, slicers and time ranges to understand the market landscape.
• Visualizations designed to support strategic planning and investment decisions.

The SNS Market Intelligence Platform consolidates years of proprietary research into a single, unified interface built for biopharma strategy, business development, competitive intelligence, and investment teams. Users can interrogate market size and forecast data by geography, subsegments and at country level. Key pipeline candidates are also presented in a structured graphical format displaying molecule type, mechanism of action, and clinical stage, enabling rapid identification of white-space opportunities and strategic inflection points.

More on The PennZone

• YWWSDC Launches AI-Native Digital Asset Infrastructure, Merging Technical Innovation with US-Standard Compliance
• High-End Exterior House Painting in Boulder, Colorado
• Simpson and Reed Co-Founders Shardé Simpson, Esq. and Ciara Reed, Esq. Launch "Hello Wilma,"
• Report Outlines Key Questions for Individuals Exploring Anxiety Treatment Options in Toronto
• Rande Vick Introduces Radical Value, Challenging How Brands Measure Long-Term Value

The launch is led by a comprehensive Dermatology In Sight module, with two focus areas: Psoriasis & Skin Cancer, and an active expansion roadmap that includes upcoming datasets on Ophthalmology (Retinal and Glaucoma), Cell & Gene Therapies, Biosimilars, and GLP-1 therapies.

Dermatology In Sight Module: Unmatched Visual Granularity
The inaugural Dermatology module provides high-resolution mapping of the global therapeutic market forecasts, segmented by mechanism of action and molecular class to deliver a precise view of competitive dynamics.

Availability and Free Trial
The SNS Market Intelligence Platform is available via annual subscription, with tiered access designed to support both emerging biotech companies and global pharmaceutical organizations. SNS Intelligence is offering a free limited trial to showcase the platforms capabilities. The Dermatology module is now live and available for a free trial via

https://www.snsintel.com/

More on The PennZone

• Lisa Mauretti Launches Peace of Mind Travel Coaching to Guide Fearful Travelers to Discover the World with Confidence
• New Year, New Home: Begin 2026 at Heritage at South Brunswick
• Food Journal Magazine Releases Its 'Best Food In Los Angeles Dining' Editorial Section
• Enders Capital: 25% Gains with Just -0.80% Maximum Monthly Drawdown in Volatile Debut Year 2025
• CES Spotlight Highlights Need for Strategic Review as Throughput Demands Evolve

About SNS Intelligence
SNS Intelligence is global market intelligence firm focused exclusively on healthcare and life sciences. By combining deep domain expertise with rigorous data structuring and advanced visualization, SNS Intelligence enables organizations to make informed decisions in complex and rapidly evolving markets.